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Abstract
Background: Boys carrying mutations in the NR0B1 gene develop adrenal hypoplasia congenita (AHC) and impaired sexual
development due to the combination of hypogonadotropic hypogonadism (HH) and primary defects in spermatogenesis.
Methods: We analysed the evolution of hypothalamic-pituitary-testicular function of 8 boys with AHC due to NR0B1
mutations. Our objective was to characterize and monitor the progressive deterioration of this function.
Results: The first symptoms appeared in the neonatal period (n=5) or between 6 months and 8.7 years (n=3). Basal plasma
adrenocorticotrophic hormone (ACTH) concentrations increased in all boys, whilst cortisol levels decreased in one case. The
natremia was equal or below 134 mmol/L and kaliemia was over 5 mmol/L. All had increased plasma renin. In 3 of 4 patients
diagnosed in the neonatal period and evaluated during the first year, the basal plasma gonadotropins concentrations, and
their response to gonadotropin releasing hormone (GnRH) test (n=2), and those of testosterone were normal. The plasma
inhibin B levels were normal in the first year of life. With the exception of two cases these concentrations decreased to
below the normal for age. Anti-Mu ¨llerian hormone concentrations were normal for age in all except one case, which had
low concentrations before the initiation of testosterone treatment. In 3 of the 8 cases the gene was deleted and the
remaining 5 cases carried frameshift mutations that are predicted to introduce a downstream nonsense mutation resulting
in a truncated protein.
Conclusions: The decreases in testosterone and inhibin B levels indicated a progressive loss of testicular function in boys
carrying NR0B1 mutations. These non-invasive examinations can help to estimate the age of the testicular degradation and
cryopreservation of semen may be considered in these cases as investigational procedure with the aim of restoring fertility.
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Introduction
The DAX-1 (dosage sensitive sex reversal, adrenal hypoplasia
congenita, critical region of the human chromosome, gene 1)
protein is an orphan member of the nuclear receptor superfamily.
It is encoded by the NR0B1 gene, which is expressed in the adrenal
cortex, gonads, hypothalamus and anterior pituitary [1]. Boys
carrying mutations in the NR0B1 gene develop adrenal failure
(adrenal hypoplasia congenital, AHC) and showed impaired sexual
development at puberty, followed by infertility. This impairment is
due to the combination of hypogonadotropic hypogonadism (HH)
[2,3,4] and a primary defect in spermatogenesis [5]. Male mice
lacking Dax-1 are infertile due at least partly to blockage of the
rete testis, with subsequent dilatation of the proximal efferent
ductules [6]. To date, more than 100 different mutations in NR0B1
have been described [7] and it has been estimated that 58% of
boys with idiopathic primary adrenal insufficiency have mutations
in NR0B1 [8].
In infants with AHC associated with NR0B1 mutations the
plasma basal testosterone, luteinising hormone (LH) and follicle
stimulating hormone (FSH) concentrations are within the normal
range and these increase following the gonadotropin releasing
hormone (GnRH) test [9,10,11]. Immunohistochemical analysis of
testicular tissue obtained from an affected sibling of one boy with
an NR0B1 mutation, who died with adrenal failure as a neonate,
showed normal testicular morphology with numerous Sertoli cells,
and expression of DAX-1, steroidogenic factor-1 (SF-1), and anti-
Mu ¨llerian hormone (AMH) proteins [12]. Conversely, in a 20- yr
old man, a testicular biopsy revealed disorganization of the normal
seminiferous tubular structure and moderate Leydig cell hyper-
plasia [13] similiar to the phenotype described in the Nr0b1
knockout mouse model [5,6]. Recently, Frapsauce et al [14]
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39828reported birth after testicular sperm extraction (TESE)-ICSI from
a 25- yr old azoospermic man with HH and AHC due to an
NR0B1 mutation.
It is difficult to predict the reproductive capacity of a child
before pubertal age because the plasma concentrations of FSH
and LH are not informative and semen analyses cannot be done.
The plasma concentrations of inhibin B and AMH might be
helpful at this age. In boys, inhibin B is produced by the Sertoli
cells. Its plasma concentration is the best plasma marker of
spermatogenesis [15,16,17]. Individual data on the plasma inhibin
B and AMH concentrations in patients with NR0B1 mutations
have been reported [13,18,19], but not during infancy and
childhood.
We analysed the evolution of hypothalamic-pituitary-testicular
function from the diagnosis to young adulthood of 8 boys with
AHC due to NR0B1 mutations, by assessing their plasma inhibin B
and AMH concentrations. Our objective was to characterize and
monitor the progressive deterioration of this function.
Results
Clinical and Biological Presentation (Table 1)
Six out of the 8 patients had a familial history of AHC. The
pregancy, delivery and mensurations at birth were normal, except
in cases 4 and 7 whose height and weight at birth were at –2
standard deviations.
The first symptoms appeared in the neonatal period (5 patients)
or between 6 mo and 8.7 yr (3 patients). In these, the diagnosis
was made between 1.5 and 8.7 yr. In case 3, the diagnosis was
made at birth by systematic screening after the brother’s history.
In the 7 others, the presenting symptom was vomiting, associated
with hypothermia (one case), abdominal pain (one case) and/or
seizures (three cases).
The plasma glucose concentration was equal or below
3.6 mmol/L in the 6 cases that were evaluated. Basal plasma
ACTH concentrations were increased in all boys, while that of
cortisol was decreased only in case 4. The natremia was equal or
below 134 mmol/L and kaliemia was over 5 mmol/L in all boys
except in case 3, who was diagnosed at birth by systematic
screening. All boys had increased plasma renin or renin activity.
The blood creatin phosphokinase enzyme and urine glycerol were
normal in all cases, indicating that there was no contiguous
deletion syndrome with Duchenne muscular dystrophy or glycerol
kinase deficiency. Five patients had an abdominal computed
tomography scan or an echography, which revealed small adrenal
glands in one patient (case 2), normal adrenal glands in 2 patients
(cases 4 and 7) and the adrenal glands were not seen in 2 patients
(case 1 and 5).
Treatment with HydrocortisoneH and 9-alpha fludrocortisone
was started in emergency in all patients. The HydrocortisoneH
replacement dose was adjusted on the basis of plasma ACTH
concentrations and that of 9-alpha fludrocortisone on renin or
renin activity. Careful and repeated information was given to the
parents and patients on the need to increase the dose of
HydrocortisoneH in case of specific events, and to replace both
HydrocortisoneH and 9-alpha fludrocortisone with injections if
there were any gastrointestinal symptoms or anaesthesia. The
psychomotor development of all the patients was normal. Five
patients reached their adult height, which was lower than their
target height, except for the case 8.
Hypothalamic-pituitary-testicular Function (Table 2)
Two brothers (cases 2 and 3) had unilateral cryptorchidism and
one of them (case 3) had been operated on in emergency at two
years of age for torsion of the inguinal testis. The volume of their
other, intrascrotal testis was 2 mL. The size of the penis was
normal in all of the boys. Cases 5 and 7 had pubic hair
development at 11 and 7 yr, despite the absence of any familial
history of early puberty.
In the 4 patients diagnosed in the neonatal period and evaluated
during the first year, the basal FSH and LH, and their response to
the GnRH test (n=2), and the basal plasma testosterone
concentrations were normal, except for case 5 who had
testosterone at 0.16 ng/mL at 14 days. With one exception, the
testicular volumes did not increase at pubertal age and the plasma
concentrations of FSH, LH and testosterone were very low or
undetectable, including during the early puberty in case 7. Case 4
had clinically and biologically onset of puberty at 13.9 yr, followed
by clinical arrest. The plasma concentrations of FSH, LH and
testosterone decreased to undetectable levels, leading to testoster-
one substitution at 17.3 yr.
The plasma inhibin B concentrations were within the normal
range in the first year of life, with a normal increase at 6 months in
case 3 (Table 2). These concentrations decreased to below the
normal range for age in all cases, except for the cases cases 1 and
7. The plasma AMH concentrations were normal for age in all
individuals except case 5 who had low concentrations before the
initiation of the testosterone treatment.
Genetic Analyses
All 8 cases carried severe mutations in the NR0B1 gene.
Case 1 is hemizygote for a c.305delG mutation at codon 102.
This mutation is predicted to result in the generation of
a downstream stop codon at position 263 (Fig 1a).
Cases 2 and 3 are brother carrying two hemizygous mutations
in exon 2. The first is an 8 bp deletion, c.1314–1321delCAT-
CAATG at codon positions 439–441. The second mutation is
a 9 bp deletion, c.1364–1372delCAGTCAGCA at codons 455–
458. These two frameshift mutations are predicted to alter the
protein sequence and result in a premature stop codon at position
455. The mother was found to be heterozygous for both of these
deletions (Fig 1b).
Case 4, 5 and 6 have complete deletions of the NR0B1 gene.
Case 5 (brother of case 6) have been previously reported [3] and
the mother was found to be heterozygous for these deletions.
Case 7 carries a hemizygous c.651delC mutation at codon 217.
Again this deletion is predicted to alter the protein sequence and
generate a premature stop codon at position 263 (Fig 1c).
Case 8 is hemizygous for a c.498delG mutation at codon
position 166. This mutations is predicted to generate a stop codon
at amino acid position 263 (Fig 1d).
In all of the boys the NR5A1 gene was sequenced as described
elsewhere [25]. No mutations were observed in the gene.
Discussion
This study shows that the plasma inhibin B, testosterone, LH,
FSH and AMH concentrations are normal in the first year of life,
and interestingly there is a normal increase in inhibin B
concentration that occurred at 6 months. The two patients
evaluated by GnRH test at this age had a normal response with
the LH peak greater than the FSH peak. A decrease of these
concentrations occurred in all the boys, with no pubertal increase
of testosterone, except a transient normal increase in one, leading
to delayed substitutive testosterone treatment. The AMH con-
centrations remained normal and did not decrease despite the
testosterone treatment. Only two patients maintained normal
plasma inhibin B concentrations at 14.8 and 16.4 yr. No
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these with normal inhibin B, sharing the same NR0B1 mutation, is
azoospermic.
Clinical and Biological Presentation
The age at the first symptom in two brothers was neonate
and 6 months. The intrafamilial variation of the age at
presentation had been reported in many unrelated families
with different mutations [10,26]. The presenting symptom was
vomiting in all cases, associated with seizures in three. All 6
evaluated had hypoglycaemia. The seizures are probably due to
the combination of the hypoglycaemia and hyponatremia.
Hypoglycemia is suggestive of cortisol deficiency, and may be
associated in the neonates with jaundice and/or low blood
pressure, or it may be isolated as observed in the present cases.
Profound persistent hypoglycemia is a clear sign if it is not
explained by other neonatal conditions. As hypoglycemia is the
best stimulus of ACTH and cortisol secretion, their plasma
concentrations should be measured during the spontaneous
hypoglycaemia whatever is the age of the patient.
The basal plasma ACTH concentrations are greatly increased
in our patients, and in those reported elsewhere. These high
concentrations stimulate cortisol secretion, explaining the
normal plasma cortisol concentrations in most of our patients,
but these nomal concentrations are insufficient to maintain
normal glucose concentrations and to prevent the seizures. In
addition, the patients are exposed to acute adrenal insufficiency
[20].
Hypothalamic-pituitary-testicular Function
In a normal infant, the plasma testosterone concentration
increases to the adult level at birth by stimulation of the Leydig
cells by human chorionic gonadotropin originating from the
placenta. This is followed by a transient postnatal activation of the
hypothalamic-pituitary-testicular axis. Thus, there is a bimodal
pattern in testosterone in male infants during the first year of life:
from birth to about the second month, a gradual increase in
testosterone occurs [24]. From the first to third months, the mean
testosterone level is significantly higher than at two weeks of life.
After one to three months, there is a gradual decrease until the
seventh month. From 7 to 12 months, the plasma testosterone
concentrations are similar to those of prepubertal children. The
increases in testosterone concentrations are associated with LH
and FSH concentrations significantly higher than in the pre-
pubertal age.
In the present study, 4/5 cases had normal testosterone
concentration during the first months, as were the basal and
GnRH stimulated LH and FSH levels. This was followed by
a decrease with secondary deficit. Only one case, with a deletion of
the NR0B1 gene, had a spontaneous puberty with a slight increase
in testicular volume, followed by a decrease of basal concentrations
with decrease in testosterone from 4.1 ng/ml at 16.8 years to
0.1 ng/ml at 17.3 years. Binder et al [27] also reported transient
onset of clinical and biological puberty in boys with NR0B1
mutations.
Habiby et al [28] have shown the phenotypic heterogeneity of
AHC/HH, and suggest that DAX-1 mutations impair gonado-
Figure 1. Mutations in DAX1 associated with AHC. Panels A, B, C and D correspond to patients 1, 3/4, 7 and 8 in table 1 respectively.
For each mutation a representative chromatogram is shown together with the sequence of a male control. The position of the mutation is indicated
by a red arrow and/or line. The consequences of the frameshift mutations on the predicted amino acid sequence is shown under each
chromatogram. In panel B, the deletion in the cDNA sequence is indicated by the highlighted bases.
doi:10.1371/journal.pone.0039828.g001
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pituitary levels. They showed that administration of human
chorionic gonadotropin (3 x 2,000 U each day) increased the
plasma testosterone concentration of their patient from 0.4 to
6.79 ng/ml by day four.
In the literature, two brothers were reported with cryptorchi-
dism and two patients had early pubertal development followed
by gonadotropins deficiency [11,26,28]. Tabarin et al [19]
reported a man who had a AHC with an NR0B1 mutation and
with a delayed-onset primary insufficiency in adulthood and an
incomplete HH. His inhibin B was dramatically decreased at
7 pg/ml. They suggested that NR0B1 should be considered
a candidate gene in young adults presenting with mild
‘‘idiopathic’’ HH.
Degradation of the Testicular Function
We evaluated the Sertoli cell function by dosing inhibin B and
AMH in all but one patient. The plasma inhibin B concentrations
were normal in the first year of life, with normal increase at 6
months in one case. These concentrations decreased to below the
normal for age in all, except in two cases. Those of AMH were
normal for age in all except one case who had low concentrations
before the initiation of the testosterone treatment. As plasma
inhibin B levels reflect the spermatogenic status throughout the
sexual maturation [29,30], our longitudinal data suggest that
spermatogenesis is normal at least during the first year of life,
followed by a degradation.
The testis of the Dax-1-deficient mice were initially shown to be
small with degeneration of the seminiferous epithelium and loss of
germ cells [6]. Jeffs et al [6] showed that there were poorly
differentiated Sertoli cells within the lumen of the seminiferous
tubules and efferent ducts and Leydig cell hyperplasia. Meeks et al
[31] have demonstrated that DAX-1 plays a crucial role in testis
differentiation by regulating the development of peritubular myoid
cells and the formation of intact testis cords. Indeed, in this study,
NR0B1 deficiency was associated with defective development of
testis cords and a decreased number of peritubular myoid cells.
In the Dax-1-deficient mouse, gonadal development is appar-
ently normal until the point of testis cord formation, suggesting
that DAX-1 plays a role in gonadal differentiation rather that
gonadal patterning or sex determination. NR0B1 mutations in
humans result in HH and infertility rather than disorder in sex
differentiation.
Mantovani et al [32] have shown that there is a gonadal
dysgenesis that is independent of the gonadotropin deficiency.
Indeed, they have treated a 28 years old man for hypogonadism
due to an NR0B1 mutation with gonadotropins during 8 months
and he did not achieve fertility after this treatment. Treatment
with exogenous gonadotropins stimulates testosterone production
but does not appear to normalize spermatogenesis in the few
individuals who have been carefully studied.
Materials and Methods
Ethics Statement
Written informed consent for the evaluation and molecular
analyses was obtained from the parents. All clinical investigations
were conducted according to the principals expressed in the
Declaration of Helsinki. The Ethical Review Committee (Comite ´
de Protection des Personnes, Ile de France III) approved the study.
This stated that ‘‘this research was found to conform to generally
accepted scientific principles and research ethical standards and to
be in conformity with the laws and regulations of the country in
which the research experiment was performed’’.
Patients
This single-centre retrospective case-cohort study was carried
out on eight consecutive patients with AHC due to NR0B1
mutations seen by a senior pediatric endocrinologist (R Brauner)
from 1990 to 2011. We excluded all patients presenting with
secondary adrenal failure due to adrenocorticotrophic hormone
(ACTH) deficiency (n=8), or primary adrenal failure associated
with gonadal dysgenesis and disorder of sexual development (n=5
from 4 families), adrenoleukodystrophy (augmentation of very-
long-chain fatty acids, n=3), autoimmune Addison’s disease
(association with other autoimmune manifestations, n=5), IM-
AGE syndrome (n=1), or congenital adrenal hyperplasia (in-
creased concentrations of 17 hydroxyprogesterone, 11-desoxycor-
tisol, 11-desoxycorticosterone or dehydroepiandrosterone). The
etiology in three other patients seen during the same period with
primary adrenal failure who did not carry NR0B1 mutations
remains undetermined.
Methods
Diagnosis of primary adrenal failure was based on increased
plasma basal ACTH concentrations (normal 10–50 pg/mL). The
concomitant cortisol concentrations were considered as low when
below 40 ng/mL in the newborn or below 80 ng/mL in the older
children in spontaneous hypoglycemia and/or at 8.00 a.m.
Diagnosis of mineraloid deficiency was based on relatively low
aldosterone concentrations in face of increased renin or plasma
renin activity, with or without hyponatremia and/or hyperkalie-
mia [20]. Pubertal development was considered as early when
pubic hair development began before 11 years.
All boys, except the cases 2 and 3, reached the pubertal age.
They were given testosterone enanthate (25 mg i.m. every
14 days) after 13 years of age for low gonadotropins and
testosterone. The doses were increased to adult levels (250 mg
i.m. every 21 days) after the end of their growth. All plasma
samples were collected before or at least one month after
testosterone administration in the patients given testosterone.
Plasma hormone concentrations were measured using different
immunoassays during the study period. A new assay method for
a given hormone was always cross-correlated with the previous
method. Thus, the results are comparable throughout the whole
period. Basal plasma concentrations of FSH, LH and testosterone
were measured in the first months of life, in the patients with early
pubertal development and/or at the pubertal age. At least one
GnRH test was performed in 6 patients. An aliquot of plasma was
frozen at 220uC to measure inhibin B [21] and AMH [22]. In the
first month of life, we used [23] and the first year [24] as normal
values.
Inhibin B was measured in the serum by an enzyme
immunometric assay (Oxford Bio-Innovation reagents, Serotec,
Oxford, UK). AMH was measured by an enzyme immuno-
metric assay (Immunotech reagents; Beckman Coulter Compa-
ny, Marseille, France). FSH and LH were measured with
a sensitive immunoradiometric assay (CIS bio international, GIF
sur Yvette, France), with a detection limit of 0.05 IU/L in both
assays (IU/L 2
nd IRP WHO 78/549 for FSH, IU/L 1
st IRP
68/40 for LH).
Sequence Analyses
DNA was isolated from peripheral blood lymphocytes using
standard techniques. The sequence analysis of the NR5A1 gene
was performed as described elsewhere [25]. The following primers
were used to amplify the NR0B1 gene: Exon1F1 59-TA-
GAAAGTCTGGTTGGAGCCTGAGATTG-39. Exon1R1 59-
GCGTTTGCTTTGAGCTAGTGAGCAAG-39 (1033 bp).
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Exon1R2 59-TCCTGATCACTGAAAACTCGTTACTGCC-39
(1071 bp). Exon2F1 59-TTGCTTCTGAAAACGTA-
GACTGGTTTGG-39, Exon2R259-ACAGAGCTATGC-
TACCTGTTGGCAAATG-39 (628 bp).
The PCR amplification conditions were, 295uC for 5 min
followed by 37 cycles of 98uC 10s, 68uC2 0s ,7 2 uC 1 min. A final
elongation step of 72uC for 10 min was added in each case. 5 mlo f
each PCR fragments were then migrated in a 2% agarose gel
stained in ethidium bromide (1 mg/mL) to verify the expected
length of the amplified fragments. DNA sequence analysis was
performed using at least 200 ng of purified DNA, 20 ng of primer
and fluorescently labelled Taq DyeDeoxy terminator reaction mix
(Applied Biosystems, Foster City, CA, USA) according to the
manufacturer’s instructions. DNA sequence was determined using
an ABI 3700 automated DNA sequencer.
Conclusion
The decreases in testosterone and inhibin B levels indicated
a progressive loss of testicular function in boys carrying NR0B1
mutations. The limitation of this retrospective study is that
measurements are not standardised in timing. These examinations
are interesting because they are non-invasive, and if they are
systematically made, they can be used to estimate the age of the
testicular degradation and plan for the cryopreservation of semen
as an investigational procedure with the aim of restoring fertility in
this group.
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